Lycia Therapeutics, Inc. (LYCA)
Nasdaq: LYCA · CIK 0001806540 · United States
Every official Lycia Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LYCA filings
Lycia Therapeutics, Inc. documents
- Lycia Therapeutics, Inc. 10-K 2026LYCA 10-K 2026: annual report for fiscal 2026
- Lycia Therapeutics, Inc. 10-K 2025LYCA 10-K 2025: annual report for fiscal 2025
- Lycia Therapeutics, Inc. 10-K 2024LYCA 10-K 2024: annual report for fiscal 2024
- Lycia Therapeutics, Inc. 10-K 2023LYCA 10-K 2023: annual report for fiscal 2023
- Lycia Therapeutics, Inc. 10-K 2022LYCA 10-K 2022: annual report for fiscal 2022
- Lycia Therapeutics, Inc. 10-Q 2026LYCA 10-Q 2026: quarterly report for fiscal 2026
- Lycia Therapeutics, Inc. 10-Q 2025LYCA 10-Q 2025: quarterly report for fiscal 2025
- Lycia Therapeutics, Inc. 10-Q 2024LYCA 10-Q 2024: quarterly report for fiscal 2024
- Lycia Therapeutics, Inc. 10-Q 2023LYCA 10-Q 2023: quarterly report for fiscal 2023
- Lycia Therapeutics, Inc. 10-Q 2022LYCA 10-Q 2022: quarterly report for fiscal 2022
- Lycia Therapeutics, Inc. 8-K 2026LYCA 8-K 2026: current report for fiscal 2026
- Lycia Therapeutics, Inc. 8-K 2025LYCA 8-K 2025: current report for fiscal 2025
- Lycia Therapeutics, Inc. 8-K 2024LYCA 8-K 2024: current report for fiscal 2024
- Lycia Therapeutics, Inc. 8-K 2023LYCA 8-K 2023: current report for fiscal 2023
- Lycia Therapeutics, Inc. 8-K 2022LYCA 8-K 2022: current report for fiscal 2022
- Lycia Therapeutics, Inc. DEF 14A 2026LYCA DEF 14A 2026: proxy statement for fiscal 2026
- Lycia Therapeutics, Inc. DEF 14A 2025LYCA DEF 14A 2025: proxy statement for fiscal 2025
- Lycia Therapeutics, Inc. DEF 14A 2024LYCA DEF 14A 2024: proxy statement for fiscal 2024
- Lycia Therapeutics, Inc. DEF 14A 2023LYCA DEF 14A 2023: proxy statement for fiscal 2023
- Lycia Therapeutics, Inc. DEF 14A 2022LYCA DEF 14A 2022: proxy statement for fiscal 2022
- Lycia Therapeutics, Inc. Form 4 2026LYCA Form 4 2026: insider trading filing for fiscal 2026
- Lycia Therapeutics, Inc. Form 4 2025LYCA Form 4 2025: insider trading filing for fiscal 2025
- Lycia Therapeutics, Inc. Form 4 2024LYCA Form 4 2024: insider trading filing for fiscal 2024
- Lycia Therapeutics, Inc. Form 4 2023LYCA Form 4 2023: insider trading filing for fiscal 2023
- Lycia Therapeutics, Inc. Form 4 2022LYCA Form 4 2022: insider trading filing for fiscal 2022
- Lycia Therapeutics, Inc. S-1 2026LYCA S-1 2026: registration statement for fiscal 2026
- Lycia Therapeutics, Inc. S-1 2025LYCA S-1 2025: registration statement for fiscal 2025
- Lycia Therapeutics, Inc. S-1 2024LYCA S-1 2024: registration statement for fiscal 2024
- Lycia Therapeutics, Inc. S-1 2023LYCA S-1 2023: registration statement for fiscal 2023
- Lycia Therapeutics, Inc. S-1 2022LYCA S-1 2022: registration statement for fiscal 2022
- Lycia Therapeutics, Inc. 13F 2026LYCA 13F 2026: institutional holdings for fiscal 2026
- Lycia Therapeutics, Inc. 13F 2025LYCA 13F 2025: institutional holdings for fiscal 2025
- Lycia Therapeutics, Inc. 13F 2024LYCA 13F 2024: institutional holdings for fiscal 2024
- Lycia Therapeutics, Inc. 13F 2023LYCA 13F 2023: institutional holdings for fiscal 2023
- Lycia Therapeutics, Inc. 13F 2022LYCA 13F 2022: institutional holdings for fiscal 2022
More companies